These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 17938810
1. Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy. Marcucci R, Paniccia R, Antonucci E, Poli S, Gori AM, Valente S, Giglioli C, Lazzeri C, Prisco D, Abbate R, Gensini GF. Thromb Haemost; 2007 Oct; 98(4):844-51. PubMed ID: 17938810 [Abstract] [Full Text] [Related]
3. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Cesari F, Marcucci R, Caporale R, Paniccia R, Romano E, Gensini GF, Abbate R, Gori AM. Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424 [Abstract] [Full Text] [Related]
4. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF. Circulation; 2009 Jan 20; 119(2):237-42. PubMed ID: 19118249 [Abstract] [Full Text] [Related]
5. Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy. Marcucci R, Gori AM, Paniccia R, Giglioli C, Buonamici P, Antoniucci D, Gensini GF, Abbate R. Atherosclerosis; 2007 Nov 20; 195(1):e217-23. PubMed ID: 17555759 [Abstract] [Full Text] [Related]
6. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes. Małek ŁA, Spiewak M, Filipiak KJ, Grabowski M, Szpotańska M, Rosiak M, Główczyńska R, Imiela T, Huczek Z, Opolski G. Kardiol Pol; 2007 Jan 20; 65(1):40-5; discussion 46. PubMed ID: 17295159 [Abstract] [Full Text] [Related]
7. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting. Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF. Thromb Haemost; 2010 Aug 20; 104(2):279-86. PubMed ID: 20508896 [Abstract] [Full Text] [Related]
8. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. J Am Coll Cardiol; 2008 Sep 30; 52(14):1128-33. PubMed ID: 18804738 [Abstract] [Full Text] [Related]
13. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. Paniccia R, Antonucci E, Maggini N, Romano E, Gori AM, Marcucci R, Prisco D, Abbate R. Am J Clin Pathol; 2009 Jun 30; 131(6):834-42. PubMed ID: 19461090 [Abstract] [Full Text] [Related]
14. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment. Paniccia R, Antonucci E, Gori AM, Marcucci R, Poli S, Romano E, Valente S, Giglioli C, Fedi S, Gensini GF, Abbate R, Prisco D. Am J Clin Pathol; 2007 Jul 30; 128(1):143-9. PubMed ID: 17580282 [Abstract] [Full Text] [Related]